Sponsored Newsletter
Learn more about this rich source of RWD and RWE
Published Jul. 28, 2022
General Newsletter
Issue
613
Biosimilar Boom on the Horizon; Bavarian Nordic Makes 1.5M Monkeypox Vaccine Deal; Biogen Settles Kickback Suit
Published Jul. 26, 2022
Sponsored Newsletter
A Master's From UC Online is Worth the Investment
Published Jul. 22, 2022
Sponsored Newsletter
Optimize Your Value Story Through Integrated Evidence Generation
Published Jul. 21, 2022
Sponsored Newsletter
The new issue of The Evidence Forum discusses topics moving drug development forward
Published Jul. 20, 2022
General Newsletter
Issue
612
HRA Pharma Files FDA Application for First OTC Birth Control Pill, China's Price Cuts Hit Astrazeneca, Pfizer, and Novartis
Published Jul. 19, 2022
Sponsored Newsletter
NEXT WEEK | Evidence Synthesis for Sparse Evidence Base, Heterogeneous Studies, and Disconnected Networks
Published Jul. 18, 2022
Jobs Newsletter
Issue
297
Eli Lilly and Company plus other industry leaders are hiring now.
Published Jul. 16, 2022
Sponsored Newsletter
How to Change Clinical Practice using Health Economics and Outcomes Research
Published Jul. 14, 2022
Sponsored Newsletter
On July 19th, join Dr. Jessica Paulus, Senior Director of Epidemiology at OM1
Published Jul. 13, 2022
General Newsletter
Issue
611
NHS England Annouces Travel Plan; India Fixes Price of 84 Drug Formulations; Bayers CKD Drug Approved in China
Published Jul. 12, 2022
Sponsored Newsletter
Trouble finding patients for your RWE study? Here's an EHR cohort of 101+ M
Published Jul. 11, 2022
Jobs Newsletter
Issue
296
New jobs for your review
Published Jul. 9, 2022
Sponsored Newsletter
UPCOMING | Optimize Your Value Story Through Integrated Evidence Generation – From Bench to Patient
Published Jul. 8, 2022
Sponsored Newsletter
ISPOR 2022: the video | Fit-for-purpose RWD | Genesis Research acquire MAT
Published Jul. 7, 2022
Sponsored Newsletter
Moving Your Cell & Gene Therapy from Evidence to Insights
Published Jul. 6, 2022
